Zhu S, Zuo S, Li C, You X, Jiang E, Feng X
J Exp Clin Cancer Res. 2025; 44(1):25.
PMID: 39856752
PMC: 11763111.
DOI: 10.1186/s13046-025-03273-2.
Mariuzza R, Singh P, Karade S, Shahid S, Sharma V
Immunol Rev. 2025; 329(1):e13435.
PMID: 39748148
PMC: 11695704.
DOI: 10.1111/imr.13435.
Yang S, Luo T, Liu H, Chen L, Wang J, Zhao Y
Genes (Basel). 2024; 15(11).
PMID: 39596644
PMC: 11594155.
DOI: 10.3390/genes15111444.
Cooksey L, Friesen D, Mangan E, Mathew P
Cells. 2024; 13(18.
PMID: 39329751
PMC: 11429815.
DOI: 10.3390/cells13181567.
Xu S, Xu Y, Chai W, Liu X, Li J, Sun L
J Thorac Dis. 2024; 16(6):3764-3781.
PMID: 38983163
PMC: 11228747.
DOI: 10.21037/jtd-24-8.
Human CD56CD39 dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss.
Jia W, Ma L, Yu X, Wang F, Yang Q, Wang X
Natl Sci Rev. 2024; 11(6):nwae142.
PMID: 38966071
PMC: 11223582.
DOI: 10.1093/nsr/nwae142.
The proportion of CD161 on CD56 NK cells in peripheral circulation associates with clinical features and disease activity of primary Sjögren's syndrome.
Zhao P, Yang Y, Song S, Cheng W, Peng C, Chang X
Immun Inflamm Dis. 2024; 12(4):e1244.
PMID: 38577997
PMC: 10996382.
DOI: 10.1002/iid3.1244.
Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.
Hipp A, Bengsch B, Globig A
Discov Immunol. 2024; 2(1):kyad010.
PMID: 38567057
PMC: 10917240.
DOI: 10.1093/discim/kyad010.
Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamous cell carcinoma.
Hu X, Dong Y, Xie S, Song Y, Yu C, He Y
J Pathol Clin Res. 2024; 10(2):e353.
PMID: 38502058
PMC: 10792702.
DOI: 10.1002/cjp2.353.
ITAM-based receptors in natural killer cells.
Aguilar O, Fong L, Lanier L
Immunol Rev. 2024; 323(1):40-53.
PMID: 38411263
PMC: 11102329.
DOI: 10.1111/imr.13313.
Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2 infection but accumulate into the lungs of COVID-19 patients.
Huang X, Kantonen J, Nowlan K, Nguyen N, Jokiranta S, Kuivanen S
Virus Res. 2024; 341:199315.
PMID: 38211733
PMC: 10826420.
DOI: 10.1016/j.virusres.2024.199315.
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological malignancies.
Alvarez Calderon F, Kang B, Kyrysyuk O, Zheng S, Wang H, Mathewson N
Blood. 2023; 143(12):1124-1138.
PMID: 38153903
PMC: 10972713.
DOI: 10.1182/blood.2023022882.
The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
Xu N, Meng X, Chu H, Yang Z, Jiao Y, Li Y
PeerJ. 2023; 11:e15654.
PMID: 37520246
PMC: 10373647.
DOI: 10.7717/peerj.15654.
Integrated analysis of single-cell and bulk RNA-sequencing reveals tumor heterogeneity and a signature based on NK cell marker genes for predicting prognosis in hepatocellular carcinoma.
Li S, Du H, Gan D, Li X, Zao X, Ye Y
Front Pharmacol. 2023; 14:1200114.
PMID: 37397471
PMC: 10307919.
DOI: 10.3389/fphar.2023.1200114.
SARS-CoV-2 infection impairs NK cell functions activation of the LLT1-CD161 axis.
Lenart M, Gorecka M, Bochenek M, Barreto-Duran E, Szczepanski A, Galuszka-Bulaga A
Front Immunol. 2023; 14:1123155.
PMID: 37287972
PMC: 10242091.
DOI: 10.3389/fimmu.2023.1123155.
Single-cell heterogeneity and dynamic evolution of Ph-like acute lymphoblastic leukemia patient with novel TPR-PDGFRB fusion gene.
Zhang X, Hou Z, Huang D, Wang F, Gao B, Zhang C
Exp Hematol Oncol. 2023; 12(1):19.
PMID: 36797781
PMC: 9936632.
DOI: 10.1186/s40164-023-00380-8.
Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms.
Soldi L, Silva V, Rabelo D, Uehara I, Silva M
J Cancer Res Clin Oncol. 2023; 149(9):6661-6673.
PMID: 36633682
DOI: 10.1007/s00432-023-04575-8.
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance.
Lao L, Zeng W, Huang P, Chen H, Jia Z, Wang P
Cancer Immunol Res. 2023; 11(3):320-338.
PMID: 36603133
PMC: 9975671.
DOI: 10.1158/2326-6066.CIR-22-0356.
Designing Cancer Immunotherapies That Engage T Cells and NK Cells.
Kyrysyuk O, Wucherpfennig K
Annu Rev Immunol. 2022; 41:17-38.
PMID: 36446137
PMC: 10159905.
DOI: 10.1146/annurev-immunol-101921-044122.
Mining the multifunction of mucosal-associated invariant T cells in hematological malignancies and transplantation immunity: A promising hexagon soldier in immunomodulatory.
Gao M, Zhao X
Front Immunol. 2022; 13:931764.
PMID: 36052080
PMC: 9427077.
DOI: 10.3389/fimmu.2022.931764.